Skip to main content
PMC home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1975 Jul;48(3):185–195.

Control of adenovirus acute respiratory disease in U.S. Army trainees.

F H Top Jr
PMCID: PMC2595226  PMID: 1099823

Abstract

Although limited almost exclusively to military trainees, acute respiratory disease (ARD) caused by adenovirus types 4 and 7 had been the leading cause of hospitalization in U.S. Army personnel. This decrease which resembles influenza in clinical manifestations led to hospitalization of as many as 50% of military trainees in midwinter and imposed a heavy burden on military hospitals and training programs. In studies undertaken from 1965 to 1970, live adenovirus type 4 and subsequently type 7 vaccines were found to be safe and immunogenic and to confer protection against type specific adenovirus ARD. For the past 5 yr. military trainees have been immunized with both adenovirus vaccines during periods of expected adenovirus disease. Since 1966, use of adenovirus vaccines has been monitored through the adenovirus surveillance program which yields weekly data on incidence and etiology of ARD in basic combat trainees. Since 1973, stable adenovirus vaccines have resulted in excellent control of adenovirus ARD. Potential problems with this immunization program are discussed.

Full text

PDF
185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellanti J. A., Artenstein M. S., Brandt B. L., Klutinis B. S., Buescher E. L. Immunoglobulin responses in serum and nasal secretions after natural adenovirus infections. J Immunol. 1969 Nov;103(5):891–898. [PubMed] [Google Scholar]
  2. Buescher E. L. Respiratory disease and the adenoviruses. Med Clin North Am. 1967 May;51(3):769–779. doi: 10.1016/s0025-7125(16)33045-0. [DOI] [PubMed] [Google Scholar]
  3. Chanock R. M., Ludwig W., Heubner R. J., Cate T. R., Chu L. W. Immunization by selective infection with type 4 adenovirus grown in human diploid tissue cultures. I. Safety and lack of oncogenicity and tests for potency in volunteers. JAMA. 1966 Feb 7;195(6):445–452. [PubMed] [Google Scholar]
  4. Collis P. B., Dudding B. A., Winter P. E., Russell P. K., Buescher E. L. Adenovirus vaccines in military recruit populations: a cost-benefit analysis. J Infect Dis. 1973 Dec;128(6):745–752. doi: 10.1093/infdis/128.6.745. [DOI] [PubMed] [Google Scholar]
  5. Dingle J. H., Langmuir A. D. Epidemiology of acute, respiratory disease in military recruits. Am Rev Respir Dis. 1968 Jun;97(6 Suppl):1–65. doi: 10.1164/arrd.1968.97.1.1. [DOI] [PubMed] [Google Scholar]
  6. Dudding B. A., Bartelloni P. J., Scott R. M., Top F. H., Jr, Russell P. K., Buescher E. L. Enteric immunization with live adenovirus type 21 vaccine. I. Tests for safety, infectivity, immunogenicity, and potency in volunteers. Infect Immun. 1972 Mar;5(3):295–299. doi: 10.1128/iai.5.3.295-299.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dudding B. A., Top F. H., Jr, Scott R. M., Russell P. K., Buescher E. L. An analysis of hospitalizations for acute respiratory disease in recruits immunized with adenovirus type 4 and type 7 vaccines. Am J Epidemiol. 1972 Feb;95(2):140–147. doi: 10.1093/oxfordjournals.aje.a121378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dudding B. A., Top F. H., Jr, Winter P. E., Buescher E. L., Lamson T. H., Leibovitz A. Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971. Am J Epidemiol. 1973 Mar;97(3):187–198. doi: 10.1093/oxfordjournals.aje.a121499. [DOI] [PubMed] [Google Scholar]
  9. Dudding B. A., Wagner S. C., Zeller J. A., Gmelich J. T., French G. R., Top F. H., Jr Fatal pneumonia associated with adenovirus type 7 in three military trainees. N Engl J Med. 1972 Jun 15;286(24):1289–1292. doi: 10.1056/NEJM197206152862403. [DOI] [PubMed] [Google Scholar]
  10. Edmondson W. P., Purcell R. H., Gundelfinger B. F., Love J. W., Ludwig W., Chanock R. M. Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. II. specific protective effect against epidemic disease. JAMA. 1966 Feb 7;195(6):453–459. [PubMed] [Google Scholar]
  11. Gilden R. V., Kern J., Lee Y. K., Rapp F., Melnick J. L., Riggs J. L., Lennette E. H., Zbar B., Rapp H. J., Turner H. C. Serologic surveys of human cancer patients for antibody to adenovirus T antigens. Am J Epidemiol. 1970 May;91(5):500–509. doi: 10.1093/oxfordjournals.aje.a121160. [DOI] [PubMed] [Google Scholar]
  12. HILLEMAN M. R. Epidemiology of adenovirus respiratory infections in military recruit populations. Ann N Y Acad Sci. 1957 Apr 19;67(8):262–272. doi: 10.1111/j.1749-6632.1957.tb46049.x. [DOI] [PubMed] [Google Scholar]
  13. HILLEMAN M. R., WERNER J. H. Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med. 1954 Jan;85(1):183–188. doi: 10.3181/00379727-85-20825. [DOI] [PubMed] [Google Scholar]
  14. Hierholzer J. C., Pumarola A., Rodriguez-Torres A., Beltran M. Occurrence of respiratory illness due to an atypical strain of adenovirus type 11 during a large outbreak in Spanish military recruits. Am J Epidemiol. 1974 Jun;99(6):434–442. doi: 10.1093/oxfordjournals.aje.a121632. [DOI] [PubMed] [Google Scholar]
  15. Kurian P. V., Lal R., Pandit V. Adenovirus infections in Indian army personnel. Indian J Med Res. 1966 Sep;54(9):812–818. [PubMed] [Google Scholar]
  16. Levin S., Dietrich J., Guillory J. Fatal nonbacterial pneumonia associated with Adenovirus type 4. Occurrence in an adult. JAMA. 1967 Sep 18;201(12):975–977. [PubMed] [Google Scholar]
  17. McAllister R. M., Gilden R. V., Green M. Adenoviruses in human cancer. Lancet. 1972 Apr 15;1(7755):831–833. doi: 10.1016/s0140-6736(72)90812-4. [DOI] [PubMed] [Google Scholar]
  18. ROWE W. P., HUEBNER R. J., GILMORE L. K., PARROTT R. H., WARD T. G. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med. 1953 Dec;84(3):570–573. doi: 10.3181/00379727-84-20714. [DOI] [PubMed] [Google Scholar]
  19. Rose H. M., Lamson T. H., Buescher E. L. Adenoviral infection in military recruits. Arch Environ Health. 1970 Sep;21(3):356–361. doi: 10.1080/00039896.1970.10667250. [DOI] [PubMed] [Google Scholar]
  20. SCHMIDT N. J., LENNETTE E. H., HO H. H. COMPARATIVE SENSITIVITY OF HUMAN FETAL DIPLOID KIDNEY CELL STRAINS AND MONKEY KIDNEY CELL CULTURES FOR ISOLATION OF CERTAIN HUMAN VIRUSES. Am J Clin Pathol. 1965 Apr;43:297–301. doi: 10.1093/ajcp/43.4.297. [DOI] [PubMed] [Google Scholar]
  21. Scott R. M., Dudding B. A., Romano S. V., Russell P. K. Enteric immunization with live adenovirus type 21 vaccine. II. Systemic and local immune responses following immunization. Infect Immun. 1972 Mar;5(3):300–304. doi: 10.1128/iai.5.3.300-304.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Smith T. J., Buescher E. L., Top F. H., Jr, Altemeier W. A., McCown J. M. Experimental respiratory infection with type 4 adenovirus vaccine in volunteers: clinical and immunological responses. J Infect Dis. 1970 Oct;122(4):239–248. doi: 10.1093/infdis/122.4.239. [DOI] [PubMed] [Google Scholar]
  23. TRENTIN J. J., YABE Y., TAYLOR G. The quest for human cancer viruses. Science. 1962 Sep 14;137(3533):835–841. doi: 10.1126/science.137.3533.835. [DOI] [PubMed] [Google Scholar]
  24. Top F. H., Jr, Buescher E. L., Bancroft W. H., Russell P. K. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis. 1971 Aug;124(2):155–160. doi: 10.1093/infdis/124.2.155. [DOI] [PubMed] [Google Scholar]
  25. Top F. H., Jr, Dudding B. A., Russell P. K., Buescher E. L. Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines. Am J Epidemiol. 1971 Aug;94(2):142–146. doi: 10.1093/oxfordjournals.aje.a121306. [DOI] [PubMed] [Google Scholar]
  26. Top F. H., Jr, Grossman R. A., Bartelloni P. J., Segal H. E., Dudding B. A., Russell P. K., Buescher E. L. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis. 1971 Aug;124(2):148–154. doi: 10.1093/infdis/124.2.148. [DOI] [PubMed] [Google Scholar]
  27. VAN DER VEEN J., KOK G. Isolation and typing of adenoviruses recovered from military recruits with acute respiratory disease in The Netherlands. Am J Hyg. 1957 Mar;65(2):119–129. doi: 10.1093/oxfordjournals.aje.a119860. [DOI] [PubMed] [Google Scholar]
  28. van der Veen J., Lambriex M. Relationship of adenovirus to lymphocytes in naturally infected human tonsils and adenoids. Infect Immun. 1973 Apr;7(4):604–609. doi: 10.1128/iai.7.4.604-609.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. van der Veen J., Oei K. G., Abarbanel M. F. Patterns of infections with adenovirus types 4, 7 and 21 in military recruits during a 9-year survey. J Hyg (Lond) 1969 Jun;67(2):255–268. doi: 10.1017/s0022172400041668. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES